734 related articles for article (PubMed ID: 37396657)
1. Microglia in Alzheimer's disease: pathogenesis, mechanisms, and therapeutic potentials.
Miao J; Ma H; Yang Y; Liao Y; Lin C; Zheng J; Yu M; Lan J
Front Aging Neurosci; 2023; 15():1201982. PubMed ID: 37396657
[TBL] [Abstract][Full Text] [Related]
2. Microglia in Alzheimer's Disease: A Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis.
Sumsuzzman DM; Uddin MS; Kabir MT; Hasana S; Perveen A; Alanazi IS; Albadrani GM; Abdel-Daim MM; Ashraf GM
Mediators Inflamm; 2022; 2022():6052932. PubMed ID: 35693110
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Bruton's Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer's Disease.
Keaney J; Gasser J; Gillet G; Scholz D; Kadiu I
J Neuroimmune Pharmacol; 2019 Sep; 14(3):448-461. PubMed ID: 30758770
[TBL] [Abstract][Full Text] [Related]
4. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
5. Microglia in Alzheimer's Disease: A Target for Therapeutic Intervention.
Zhang G; Wang Z; Hu H; Zhao M; Sun L
Front Cell Neurosci; 2021; 15():749587. PubMed ID: 34899188
[TBL] [Abstract][Full Text] [Related]
6. Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules.
Althafar ZM
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807370
[TBL] [Abstract][Full Text] [Related]
7. Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer's Disease.
Xu YJ; Au NPB; Ma CHE
Front Aging Neurosci; 2022; 14():896852. PubMed ID: 35693341
[TBL] [Abstract][Full Text] [Related]
8. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches.
Ahmad MH; Fatima M; Mondal AC
J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170
[TBL] [Abstract][Full Text] [Related]
9. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
10. Microglia in Alzheimer's Disease: An Unprecedented Opportunity as Prospective Drug Target.
Kulkarni B; Cruz-Martins N; Kumar D
Mol Neurobiol; 2022 May; 59(5):2678-2693. PubMed ID: 35149973
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
Thawkar BS; Kaur G
J Neuroimmunol; 2019 Jan; 326():62-74. PubMed ID: 30502599
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.
Wang M; Tang G; Zhou C; Guo H; Hu Z; Hu Q; Li G
Chem Biol Interact; 2023 Apr; 375():110387. PubMed ID: 36758888
[TBL] [Abstract][Full Text] [Related]
13. DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.
Lv J; Wang W; Zhu X; Xu X; Yan Q; Lu J; Shi X; Wang Z; Zhou J; Huang X; Wang J; Duan W; Shen X
Brain Behav Immun; 2020 Nov; 90():55-69. PubMed ID: 32739363
[TBL] [Abstract][Full Text] [Related]
14. Targeting Microglial Population Dynamics in Alzheimer's Disease: Are We Ready for a Potential Impact on Immune Function?
Martin-Estebane M; Gomez-Nicola D
Front Cell Neurosci; 2020; 14():149. PubMed ID: 32581720
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological targeting of microglia dynamics in Alzheimer's disease: Preclinical and clinical evidence.
Yousefizadeh A; Piccioni G; Saidi A; Triaca V; Mango D; Nisticò R
Pharmacol Res; 2022 Oct; 184():106404. PubMed ID: 35988869
[TBL] [Abstract][Full Text] [Related]
16. New Insights into Microglial Mechanisms of Memory Impairment in Alzheimer's Disease.
Li N; Deng M; Hu G; Li N; Yuan H; Zhou Y
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421736
[TBL] [Abstract][Full Text] [Related]
17. Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.
Spangenberg EE; Green KN
Brain Behav Immun; 2017 Mar; 61():1-11. PubMed ID: 27395435
[TBL] [Abstract][Full Text] [Related]
18. The effects of microglia-associated neuroinflammation on Alzheimer's disease.
Wang C; Zong S; Cui X; Wang X; Wu S; Wang L; Liu Y; Lu Z
Front Immunol; 2023; 14():1117172. PubMed ID: 36911732
[TBL] [Abstract][Full Text] [Related]
19. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
20. Microglia-Mediated Synapse Loss in Alzheimer's Disease.
Rajendran L; Paolicelli RC
J Neurosci; 2018 Mar; 38(12):2911-2919. PubMed ID: 29563239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
